Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2019
Sir Andrew Dillon to stand down as NICE chief executive
22 August 2019 - Sir Andrew Dillon has announced his intention to stand down as NICE chief executive next year. ...
Posted by Michael Wonder on 25 Aug 2019
Cannabis oil too expensive to prescribe to epileptic children on NHS, advisory body finds
23 August 2019 - A cannabis drug used to treat children with epilepsy is too expensive to prescribe even though ...
Posted by Michael Wonder on 25 Aug 2019
Medipost’s Pneumostem gets FDA’s fast-track designation
23 August 2019 - Medipost said that the U.S. FDA has given a fast- track designation for Pneumostem, a bronchopulmonary ...
Posted by Michael Wonder on 25 Aug 2019
Time for FDA to release complete responses letters? Debate reignites.
23 August 2019 - The idea of the US FDA releasing complete response letters resurfaced this week as Sarepta Therapeutics ...
Posted by Michael Wonder on 25 Aug 2019
Opioid addiction meds to be free under PBS
25 August 2019 - The more than 110,000 Australians struggling with opioid dependency could have access to medication to help ...
Posted by Michael Wonder on 24 Aug 2019
Life changing drugs almost nobody can afford
23 August 2019 - Patients suffering from rare diseases who had little hope for a treatment now have access to ...
Posted by Michael Wonder on 24 Aug 2019
Trump has made a priority of trying to lower drug prices. But many of his most ardent supporters don’t know it.
23 August 2019 - The contrast between the two Trump rallies was striking: At one event here in the first ...
Posted by Michael Wonder on 24 Aug 2019
China vows to maintain stable drug prices
22 August 2019 - Chinese authorities vowed to take actions to make sure the drug prices are set reasonably by ...
Posted by Michael Wonder on 24 Aug 2019
Companies file suit in Canada challenging new rules to lower drug prices
23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...
Posted by Michael Wonder on 23 Aug 2019
Recommendations made by the PBAC - July 2019
23 August 2019 - The recommendations from the July 2019 PBAC meeting are now available. ...
Posted by Michael Wonder on 23 Aug 2019
FDA focuses on Novartis delay in reporting drug-test data manipulation
22 August 2019 - Regulators zeroing in on the company’s two-month delay in launching a formal inquiry. ...
Posted by Michael Wonder on 23 Aug 2019
Australia’s deadliest cancer has a new treatment
23 August 2019 - A powerful new combination treatment for Australia’s deadliest cancer has been approved for subsidy in a move ...
Posted by Michael Wonder on 23 Aug 2019
Life-saving cystic fibrosis drug Orkambi added to the PBS for children between two and five, bringing hope to families
23 August 2019 - ...
Posted by Michael Wonder on 23 Aug 2019
NICE to work with company on addressing issues in appraisals of cannabidiol for treating difficult to control epilepsies
23 August 2019 - NICE has today announced its intention to work with GW Pharma to address the issues highlighted by ...
Posted by Michael Wonder on 23 Aug 2019
Medibank joins Nexus Hospitals joint replacement surgery trial guaranteeing zero out-of-pocket costs
23 August 2019 - Doctors, Nexus Hospitals and Medibank start innovative joint replacement trial. ...
Posted by Michael Wonder on 22 Aug 2019
PTAC continues to find new ways to reject new medicines (Part 2)
23 August 2019 - More startling insights from the minutes of the May 2019 PTAC meeting. ...